1. Home
  2. THG vs BIO Comparison

THG vs BIO Comparison

Compare THG & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THG
  • BIO
  • Stock Information
  • Founded
  • THG 1852
  • BIO 1952
  • Country
  • THG United States
  • BIO United States
  • Employees
  • THG N/A
  • BIO N/A
  • Industry
  • THG Property-Casualty Insurers
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • THG Finance
  • BIO Industrials
  • Exchange
  • THG Nasdaq
  • BIO Nasdaq
  • Market Cap
  • THG 6.1B
  • BIO 6.2B
  • IPO Year
  • THG 1995
  • BIO N/A
  • Fundamental
  • Price
  • THG $176.15
  • BIO $226.40
  • Analyst Decision
  • THG Buy
  • BIO Strong Buy
  • Analyst Count
  • THG 9
  • BIO 4
  • Target Price
  • THG $179.00
  • BIO $330.50
  • AVG Volume (30 Days)
  • THG 218.3K
  • BIO 374.2K
  • Earning Date
  • THG 04-30-2025
  • BIO 07-31-2025
  • Dividend Yield
  • THG 2.05%
  • BIO N/A
  • EPS Growth
  • THG 167.70
  • BIO N/A
  • EPS
  • THG 12.02
  • BIO N/A
  • Revenue
  • THG $6,289,500,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • THG $5.52
  • BIO N/A
  • Revenue Next Year
  • THG $5.73
  • BIO $3.69
  • P/E Ratio
  • THG $14.66
  • BIO N/A
  • Revenue Growth
  • THG 3.09
  • BIO N/A
  • 52 Week Low
  • THG $119.66
  • BIO $215.38
  • 52 Week High
  • THG $176.71
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • THG 66.56
  • BIO 41.49
  • Support Level
  • THG $163.48
  • BIO $220.31
  • Resistance Level
  • THG $170.80
  • BIO $233.28
  • Average True Range (ATR)
  • THG 3.10
  • BIO 8.26
  • MACD
  • THG 0.82
  • BIO -1.40
  • Stochastic Oscillator
  • THG 95.99
  • BIO 16.29

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: